ONS CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATE ACTUAL EXAM QUESTIONS
AND CORRECT ANSWERS COMPLETE
STUDY GUIDE
●● What teaching is included regarding nausea and vomiting for a
patient with multiple myeloma scheduled for bortezomib? The
emetogenic risk level is:
a) low and dexamethasone is prescribed
b) minimal and routine prophylaxis is unnecessary
c) moderate and aprepitant is ordered
d) high and dronabinol is necessary
Answer: b) minimal and routine prophylaxis is unnecessary
●● A patient receiving an initial infusion of ofatumumab begins
experiencing a rash, fever and dyspnea. What is the patient likely
experiencing?
a) Stevens-Johnson syndrome
b) Non-IgE mediated allergic reaction
c) Idiosyncratic adverse drug reaction
d) Cytokine release syndrome
,Answer: d) Cytokine release syndrome
●● Which immunotherapy agent is approved for the treatment of
sarcomas?
a) Ramucirumab
b) Daratumumab
c) Olaratumab
d) Atezolizumab
Answer: c) Olaratumab
●● Patients who are prescribed carmustine or lomustine will receive
doses no more frequently than every six weeks due to what medication
property?
a) reduced medication efficacy
b) nitrosoureas cross the blood-brain barrier
c) delayed myelosuppression
d) cutaneous hyperpigmentation
Answer: c) delayed myelosuppression
●● Prior to carboplatin administration, the nurse:
, a) recalculates dose using total area of skin expressed in square meters
b) verifies orders based on previously administered doses
c) compares standard and non-standard protocols for treatment
d) reviews recent laboratory results for needed dose adjustments
Answer: a) recalculates dose using total area of skin expressed in square
meters
●● The nurse preparing to administer etoposide understands that
appropriate personal protective equipment includes gloves that are:
a) tested for permeability
b) puncture proof
c) resistant to sweat
d) made of only nitrile
Answer: d) made of only nitrile
●● Which of the following medications has a cumulative dose effect
resulting in neurotoxicities?
a) Doxorubican
b) Bleomycin
c) Mitomycin
d) Paclitaxel
CERTIFICATE ACTUAL EXAM QUESTIONS
AND CORRECT ANSWERS COMPLETE
STUDY GUIDE
●● What teaching is included regarding nausea and vomiting for a
patient with multiple myeloma scheduled for bortezomib? The
emetogenic risk level is:
a) low and dexamethasone is prescribed
b) minimal and routine prophylaxis is unnecessary
c) moderate and aprepitant is ordered
d) high and dronabinol is necessary
Answer: b) minimal and routine prophylaxis is unnecessary
●● A patient receiving an initial infusion of ofatumumab begins
experiencing a rash, fever and dyspnea. What is the patient likely
experiencing?
a) Stevens-Johnson syndrome
b) Non-IgE mediated allergic reaction
c) Idiosyncratic adverse drug reaction
d) Cytokine release syndrome
,Answer: d) Cytokine release syndrome
●● Which immunotherapy agent is approved for the treatment of
sarcomas?
a) Ramucirumab
b) Daratumumab
c) Olaratumab
d) Atezolizumab
Answer: c) Olaratumab
●● Patients who are prescribed carmustine or lomustine will receive
doses no more frequently than every six weeks due to what medication
property?
a) reduced medication efficacy
b) nitrosoureas cross the blood-brain barrier
c) delayed myelosuppression
d) cutaneous hyperpigmentation
Answer: c) delayed myelosuppression
●● Prior to carboplatin administration, the nurse:
, a) recalculates dose using total area of skin expressed in square meters
b) verifies orders based on previously administered doses
c) compares standard and non-standard protocols for treatment
d) reviews recent laboratory results for needed dose adjustments
Answer: a) recalculates dose using total area of skin expressed in square
meters
●● The nurse preparing to administer etoposide understands that
appropriate personal protective equipment includes gloves that are:
a) tested for permeability
b) puncture proof
c) resistant to sweat
d) made of only nitrile
Answer: d) made of only nitrile
●● Which of the following medications has a cumulative dose effect
resulting in neurotoxicities?
a) Doxorubican
b) Bleomycin
c) Mitomycin
d) Paclitaxel